News and Trends 15 Nov 2022
Avanzanite Bioscience looks to commercialize innovative medicines for rare diseases in Europe
Avanzanite Bioscience B.V. has officially launched its commercial-stage enterprise, to expand patient access to medicines for rare diseases in Europe…